Serina Therapeutics's market cap is currently $50.95M. The company's EPS TTM is $-0.66; its P/E ratio is ―; Serina Therapeutics is scheduled to report earnings on August 11, 2025, and the estimated EPS forecast is $-0.53. See an overview of income statement, balance sheet, and cash flow financials.
